{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T10:08:21Z","timestamp":1756634901212},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["PR9"],"published-print":{"date-parts":[[2019,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Introduction:<\/jats:title>\n            <jats:p>In the field of pain research, clinical trials may randomize over 500 subjects and include more than 150 sites spanning over a dozen countries.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>This review examines the ethical considerations affecting clinical trial design, execution, and analysis of trials for chronic pain. The Belmont Report has been the touchstone for human studies protection efforts since 1979. Commissioned by the U.S. government in response to ethical failures in medical research, such as the Tuskegee Syphilis Study, the report emphasizes 3 basic principles: respect for persons, beneficence, and justice. Trial design and sample size have important ethical implications.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Measures to enhance trial transparency and combat publication and many other types of bias should be implemented.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/pr9.0000000000000646","type":"journal-article","created":{"date-parts":[[2018,3,29]],"date-time":"2018-03-29T21:25:52Z","timestamp":1522358752000},"page":"e646","source":"Crossref","is-referenced-by-count":3,"title":["Ethical considerations in the design, execution, and analysis of clinical trials of chronic pain treatments"],"prefix":"10.1097","volume":"4","author":[{"given":"Michael C.","family":"Rowbotham","sequence":"first","affiliation":[{"name":"California Pacific Medical Center Research Institute, San Francisco, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael P.","family":"McDermott","sequence":"additional","affiliation":[{"name":"Center for Human Experimental Therapeutics, University of Rochester Medical Center, Rochester, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2019,5]]},"reference":[{"key":"R1-20230824","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1136\/jme.2003.006155","article-title":"Sham surgery controls are mitigated trolleys","volume":"31","author":"Albin","year":"2005","journal-title":"J Med Ethics"},{"key":"R2-20230824","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.seizure.2011.01.004","article-title":"Combining antiepileptic drugs\u2014rational polytherapy?","volume":"20","author":"Brodie","year":"2011","journal-title":"Seizure"},{"key":"R3-20230824","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nrn3475","article-title":"Power failure: why small sample size undermines the reliability of neuroscience","volume":"14","author":"Button","year":"2013","journal-title":"Nat Rev Neurosci"},{"key":"R5-20230824","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1056\/NEJMe048225","article-title":"Clinical trial registration: a statement from the international committee of medical journal editors","volume":"351","author":"De Angelis","year":"2004","journal-title":"N Engl J Med"},{"key":"R6-20230824","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1001\/jama.1990.03440100097014","article-title":"The existence of publication bias and risk factors for its occurrence","volume":"263","author":"Dickersin","year":"1990","journal-title":"JAMA"},{"key":"R7-20230824","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.pain.0000000000000009","article-title":"Results availability for analgesic device, complex regional pain syndrome, and post-stroke pain trials: comparing the RReADS, RReACT, and RReMiT databases","volume":"156","author":"Dufka","year":"2015","journal-title":"PAIN"},{"key":"R8-20230824","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1016\/j.pain.2010.11.008","article-title":"Evidence-based clinical trial design for chronic pain pharmacotherapy: a blueprint for ACTION","volume":"152","author":"Dworkin","year":"2011","journal-title":"PAIN"},{"key":"R9-20230824","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.pain.2010.02.018","article-title":"Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations","volume":"149","author":"Dworkin","year":"2010","journal-title":"PAIN"},{"key":"R10-20230824","doi-asserted-by":"crossref","first-page":"464","DOI":"10.7326\/0003-4819-133-6-200009190-00015","article-title":"Placebo-controlled trials and active-control trials in the evaluation of new treatments, part 2: practical issues and specific cases","volume":"133","author":"Ellenberg","year":"2000","journal-title":"Ann Intern Med"},{"key":"R11-20230824","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0304-3959(89)90110-3","article-title":"Dynamics and significance of placebo response in primary dysmenorrhea","volume":"36","author":"Fedele","year":"1989","journal-title":"PAIN"},{"key":"R12-20230824","doi-asserted-by":"crossref","first-page":"400","DOI":"10.7326\/0003-4819-153-6-201009210-00008","article-title":"Clinical trials: discerning hype from substance","volume":"153","author":"Fleming","year":"2010","journal-title":"Ann Intern Med"},{"key":"R13-20230824","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1056\/NEJM198707163170304","article-title":"Equipoise and the ethics of clinical research","volume":"317","author":"Freedman","year":"1987","journal-title":"N Engl J Med"},{"key":"R14-20230824","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1056\/NEJM199909233411311","article-title":"Use of placebo surgery in controlled trials of a cellular-based therapy for Parkinson's disease","volume":"341","author":"Freeman","year":"1999","journal-title":"N Engl J Med"},{"key":"R15-20230824","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1056\/NEJMra1614394","article-title":"Evidence for health decision-making\u2014beyond randomized, controlled trials","volume":"377","author":"Frieden","year":"2017","journal-title":"N Engl J Med"},{"key":"R16-20230824","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1056\/NEJMoa042580","article-title":"Morphine, gabapentin, or their combination for neuropathic pain","volume":"352","author":"Gilron","year":"2005","journal-title":"N Engl J Med"},{"key":"R17-20230824","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1056\/NEJMra1411250","article-title":"Enduring and emerging challenges of informed consent","volume":"372","author":"Grady","year":"2015","journal-title":"N Engl J Med"},{"key":"R18-20230824","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1056\/NEJMra1603773","article-title":"Informed consent","volume":"376","author":"Grady","year":"2017","journal-title":"N Engl J Med"},{"key":"R19-20230824","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1016\/j.pain.2012.06.004","article-title":"A snapshot and scorecard for analgesic clinical trials for chronic pain: the RReACT database","volume":"153","author":"Greene","year":"2012","journal-title":"PAIN"},{"key":"R22-20230824","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/AJP.0b013e3181b12dec","article-title":"Enriched enrollment randomized withdrawal trial designs of analgesics\u2014focus on methodology","volume":"25","author":"Katz","year":"2009","journal-title":"Clin J Pain"},{"key":"R23-20230824","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJM200002033420503","article-title":"Early identification of refractory epilepsy","volume":"342","author":"Kwan","year":"2000","journal-title":"N Engl J Med"},{"key":"R24-20230824","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1136\/jme.2005.013169","article-title":"Benefits, risks and ethical considerations in translation of stem cell research to clinical applications in Parkinson's disease","volume":"33","author":"Master","year":"2007","journal-title":"J Med Ethics"},{"key":"R25-20230824","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1745-6215-11-37","article-title":"Reporting bias in medical research\u2014a narrative review","volume":"11","author":"McGauran","year":"2010","journal-title":"Trials"},{"key":"R26-20230824","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1177\/014107680409701205","article-title":"Sham procedures and the ethics of clinical trials","volume":"97","author":"Miller","year":"2004","journal-title":"J R Soc Med"},{"key":"R28-20230824","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ana.10720","article-title":"A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease","volume":"54","author":"Olanow","year":"2003","journal-title":"Ann Neurol"},{"key":"R29-20230824","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1001\/jama.279.3.222","article-title":"Run-in periods in randomized trials: implications for the application of results in clinical practice","volume":"279","author":"Pablos-M\u00e9ndez","year":"1998","journal-title":"JAMA"},{"key":"R30-20230824","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.pain.2008.06.024","article-title":"Placebo response in neuropathic pain trials","volume":"138","author":"Quessy","year":"2008","journal-title":"PAIN"},{"key":"R31-20230824","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.pain.2009.09.026","article-title":"The case for publishing \u201cnegative\u201d clinical trials","volume":"146","author":"Rowbotham","year":"2009","journal-title":"PAIN"},{"key":"R32-20230824","doi-asserted-by":"crossref","first-page":"e58603","DOI":"10.1371\/journal.pone.0058603","article-title":"Interactive informed consent: randomized comparison with paper consents","volume":"8","author":"Rowbotham","year":"2013","journal-title":"PLoS One"},{"key":"R33-20230824","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1513\/pats.200707-090JK","article-title":"Sham procedure versus usual care as the control in clinical trials of devices","volume":"4","author":"Sutherland","year":"2007","journal-title":"Proc Am Thorac Soc"},{"key":"R34-20230824","doi-asserted-by":"crossref","first-page":"455","DOI":"10.7326\/0003-4819-133-6-200009190-00014","article-title":"Placebo-controlled trials and active-control trials in the evaluation of new treatments, part 1: ethical and scientific issues","volume":"133","author":"Temple","year":"2000","journal-title":"Ann Intern Med"},{"key":"R35-20230824","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMsa065779","article-title":"Selective publication of antidepressant trials and its influence on apparent efficacy","volume":"358","author":"Turner","year":"2008","journal-title":"N Engl J Med"},{"key":"R36-20230824","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1212\/WNL.51.4.1166","article-title":"Nortriptyline versus amitriptyline in postherpetic neuralgia: a randomized trial","volume":"51","author":"Watson","year":"1998","journal-title":"Neurology"},{"key":"R37-20230824","doi-asserted-by":"crossref","first-page":"566","DOI":"10.15252\/embr.201540398","article-title":"The ethics of global clinical trials","volume":"16","author":"Weigmann","year":"2015","journal-title":"EMBO Rep"},{"key":"R39-20230824","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"310","year":"2013","journal-title":"JAMA"}],"container-title":["PAIN Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/01938936-201906000-00030","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T17:07:14Z","timestamp":1692896834000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01938936-201906000-00030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/pr9.0000000000000646","relation":{},"ISSN":["2471-2531"],"issn-type":[{"value":"2471-2531","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5]]}}}